NEW YORK (TheStreet) -- CHANGE IN RATINGS
Charles River Labs
upgraded at Goldman from Sell to Neutral. Management has lowered guidance to a reasonable level.
upgraded at Morgan Stanley to Overweight. $28 price target. See better broadband pricing and the potential to gain market share in the commercial area.
rated new Neutral at Goldman Sachs. $22 price target. Company is facing significantly higher fluid milk prices.
upgraded at Morgan Stanley from Underweight to Equal-weight. $39 price target. Company boosted its earnings guidance, to reflect cost-cutting and better non-regulated earnings.
upgraded at Barclays to Equal Weight from Underweight on belief that the company will post about consensus 3Q results. Price target increased by a dollar to $8. 2009 EPS estimate raised to -$0.92 from -$1.10, and 2010 lifted to $0.70 from $0.55.
downgraded at Goldman from Buy to Neutral. $16 price target. Competition is driving down prices, and the company appears to be losing market share.
downgraded at Goldman from Buy to Neutral. $7 price target. Pricing war continues, as the company loses market share to Boost Mobile.
( PTV) downgraded at Barclays to Equal Weight from Overweight on higher costs and lower dollar. 2009 and 2010 EPS estimates increased to $2.47 from $2.45 and to $2.60 from $2.50, respectively. Price target increased to $28 from $27.
upgraded at Barclays from Underweight to Equal Weight. 2009 and 2010 EPS estimates raised to $1.40 from $1.35 and to $1.70 from $1.55, respectively. Price target lifted to $22 from $16.
downgraded at Goldman from Buy to Neutral. Stock was also removed from the Conviction List. $25 price target. Company has missed expectations two straight quarters, and international growth could continue to disappoint.
STOCK COMMENTS / EPS CHANGES
price target lifted at Credit Suisse to $250 from $235. Maintain Outperform rating. 2010 and 2011 EPS estimates set at $7.76 and $9.69, respectively
price target boosted at Barclays to $235 from $208 on strong 4Q results. 2010 EPS estimate increased to $7.55 from $6.75. Maintain Overweight rating.
( ATHR) numbers boosted at FBR. Shares to $34. Estimates also increased, to reflect the company's new guidance. Market Perform rating.
estimates raised at UBS through 2010. Company is seeing better margins, but credit issues could linger for a couple of years. Sell rating and $21 price target.
estimates lowered at FBR through 2010. Commercial loans are starting to show more problems. Market Perform rating and $25 price target.
Check Point Software
price target boosted at Credit Suisse to $35 from $30. 2009 and 2010 EPS estimates set at $1.96 and $2.24, respectively. Reiterate Outperform rating.
numbers raised at Morgan Stanley. Shares now seen reaching $18. Estimates also increased, to reflect higher expected broadband prices. Equal-weight rating.
price target, estimates boosted at Barclays. Price target lifted to $62 from $60 after posting better than expected 3Q results. 2009 and 2010 EPS estimates raised to $2.10 from $1.60 and to $3.75 from $2.85, respectively. Maintain Equal Weight rating.
estimates, target increased at Goldman. Estimates were raised through 2011. Company still benefiting from cost cutting. Neutral rating and new $69 price target.
numbers boosted at UBS. Shares now seen reaching $16. Estimates also raised, to reflect backlog growth and better industrial margins. Neutral rating.
estimates, target lowered at Citigroup. Estimates were reduced through 2011. Company will be hurt by a power outage in Taiwan, which will hurt glass output. Buy rating and new $20 price target.
price target, estimates higher at Barclays. Price target increased to $37 from $30. 2009 and 2010 EPS estimates raised to $2.80 from $2.73 and to $2.45 from $2.25, respectively. Reiterate Equal Weight rating.
estimates, target raised at Goldman. Shares of IEX now seen reaching $34. Estimates also boosted, to reflect a higher margin outlook. Neutral rating.
numbers raised at Citigroup. Shares now seen reaching $30. Estimates also boosted, to reflect the acquisition of the MS retail asset management business. Buy rating.
price target higher at Credit Suisse to $29 from $27. Reiterate Outperform rating. 2009 and 2010 EPS estimates set at $0.74 and $1.36, respectively.
price target, estimates lifted at Barclays. Price target increased to $27 from $21. 2009 and 2010 EPS estimates increased to $3.19 from $3.09 and to $3.80 from $3.70, respectively. Maintain Underweight rating.
estimates, target boosted at Goldman. Estimates were raised through 2011. Company is seeing better gross margins. Neutral rating and new $28 price target.
numbers lowered at Goldman. Shares now seen reaching $21. Estimates also cut, to reflect lower containerboard prices. Neutral rating.
numbers raised at Goldman. Shares now seen reaching $46. Estimates also increased, to reflect higher sales trends and expected square footage growth. Buy rating.
estimates, target upped at FBR. TXN estimates were raised through 2010. Company now seeing sequential revenue growth for the fourth quarter. Market Perform rating and $31 price target.
target raised, estimates mixed at Barclays. Price target lifted to $55 from $51. 2009 EPS estimate raised to -$2.33 from -$2.42, 2010 lowered to -$0.75 from -$0.50. Maintain Overweight rating.
estimates cut at FBR through 2010. Company seeing higher loss provisions. Outperform rating and $20 price target.
This article was written by a staff member of TheStreet.com.